Reuters logo
BRIEF-Cellectis shares rise 50 pct after Pfizer deal
June 18, 2014 / 7:16 AM / 3 years ago

BRIEF-Cellectis shares rise 50 pct after Pfizer deal

PARIS, June 18 (Reuters) - Cellectis SA : * Shares rise 50 percent after signs deal with Pfizer to develop

immunotherapy drugs in cancer

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below